MELANIE VOGT-MCCLOY: Open Payments
NPI 1609532233 · PARKERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 15 payments from 7 companies in 2025. Trend: 2023 $412 · 2024 $200 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Alkermes, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, UZEDY, ARISTADA, INVEGA SUSTENNA, REXULTI.
Industry payments across WV — which companies pay providers there.
